183 related articles for article (PubMed ID: 2860892)
1. Combined pharmacological and behavioral treatment for agoraphobia.
Telch MJ; Agras WS; Taylor CB; Roth WT; Gallen CC
Behav Res Ther; 1985; 23(3):325-35. PubMed ID: 2860892
[No Abstract] [Full Text] [Related]
2. Clinically significant improvement in agoraphobia research.
Mavissakalian M
Behav Res Ther; 1986; 24(3):369-70. PubMed ID: 2873811
[No Abstract] [Full Text] [Related]
3. Combined behavioral therapy and pharmacotherapy of agoraphobia.
Mavissakalian M
J Psychiatr Res; 1993; 27 Suppl 1():179-91. PubMed ID: 7908332
[TBL] [Abstract][Full Text] [Related]
4. Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
Klein DF; Ross DC; Cohen P
Arch Gen Psychiatry; 1987 Apr; 44(4):377-85. PubMed ID: 2882736
[TBL] [Abstract][Full Text] [Related]
5. Treating agoraphobia.
Barley WD
Hosp Community Psychiatry; 1984 Jul; 35(7):733. PubMed ID: 6146561
[No Abstract] [Full Text] [Related]
6. Behavioural and combined therapy in panic states.
Pecknold JC
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):97-104. PubMed ID: 2888162
[TBL] [Abstract][Full Text] [Related]
7. Cognitive change during treatment of agoraphobia. Behavioral and cognitive-behavioral approaches.
Last CG; Barlow DH; O'Brien GT
Behav Modif; 1984 Apr; 8(2):181-210. PubMed ID: 6148064
[No Abstract] [Full Text] [Related]
8. Self-exposure treatment of agoraphobia.
Frame CL; Turner SM; Jacob RG; Szekely B
Behav Modif; 1984 Jan; 8(1):115-22. PubMed ID: 6148062
[No Abstract] [Full Text] [Related]
9. Differential effects of imipramine and behavior therapy on panic disorder with agoraphobia.
Mavissakalian M
Psychopharmacol Bull; 1989; 25(1):27-9. PubMed ID: 2672069
[No Abstract] [Full Text] [Related]
10. Desensitization treatment of agoraphobia.
James JE
Br J Clin Psychol; 1985 May; 24 ( Pt 2)():133-4. PubMed ID: 2860939
[TBL] [Abstract][Full Text] [Related]
11. Transfer of behavioral change across phobias in multiply phobic clients.
Williams SL; Kleifield E
Behav Modif; 1985 Jan; 9(1):22-31. PubMed ID: 2858196
[No Abstract] [Full Text] [Related]
12. Imipramine with or without cognitive-behavior therapy in the treatment of an agoraphobic.
Last CG; Barlow DH; O'Brien GT
Psychol Rep; 1983 Aug; 53(1):103-14. PubMed ID: 6635054
[No Abstract] [Full Text] [Related]
13. Drug therapy for agoraphobia.
Scott WB; Fleming BM; Kritkausky RP
Arch Gen Psychiatry; 1988 Apr; 45(4):387-8. PubMed ID: 2895622
[No Abstract] [Full Text] [Related]
14. Comparison of short-term treatment regimens in phobic patients: a preliminary report.
Zitrin CM; Klein DF; Lindemann C; Tobak P; Rock M; Kaplan JE; Ganz VH
Proc Annu Meet Am Psychopathol Assoc; 1976; (64):233-50. PubMed ID: 4791
[No Abstract] [Full Text] [Related]
15. Predicting the outcome of behaviour therapy for agoraphobia.
Hafner RJ; Ross MW
Behav Res Ther; 1983; 21(4):375-82. PubMed ID: 6138026
[No Abstract] [Full Text] [Related]
16. Hazards of in vivo exposure.
Jackson HJ
Aust N Z J Psychiatry; 1984 Sep; 18(3):290. PubMed ID: 6148930
[No Abstract] [Full Text] [Related]
17. The treatment of agoraphobia. A comparison of self-instructional training, rational emotive therapy, and exposure in vivo.
Emmelkamp PM; Brilman E; Kuiper H; Mersch PP
Behav Modif; 1986 Jan; 10(1):37-53. PubMed ID: 2870708
[No Abstract] [Full Text] [Related]
18. Treating a man who cannot go out alone, feels bound to his ailing mother.
Zitrin CM
Hosp Community Psychiatry; 1984 Mar; 35(3):225-6, 231. PubMed ID: 6142858
[No Abstract] [Full Text] [Related]
19. Cognitive changes during in vivo exposure in an agoraphobic.
Last CG; Barlow DH; O'Brien GT
Behav Modif; 1984 Jan; 8(1):93-113. PubMed ID: 6148063
[No Abstract] [Full Text] [Related]
20. Compliance as a factor in outcome with agoraphobic clients.
Liddell A; Mackay W; Dawe G; Galutira B; Hearn S; Walsh-Doran M
Behav Res Ther; 1986; 24(2):217-20. PubMed ID: 2870706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
